News
China Medical System targets second growth phase with Singapore listing as gateway to Southeast Asia
With its international strategy in place, CMS sees its SGX listing as more than a milestone but a launchpad for its expansion ...
CoreWeave had an exciting H1'25 performance, thanks to the IPO, the demand for its neocloud, and the consequently rich ...
NTT DC REIT’s IPO was supposed to be a shot in the arm for Singapore’s flagging equity market, decried by analysts as ...
Adobe's AI innovations lack financial impact, with sluggish growth and marginal profitability gains. See why I'm downgrading ...
CMS is a specialty pharmaceutical company with strong presence in China for nearly 30 years. Listed on the Hong Kong Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results